Data for: Stereotactic Ablative Body Radiotherapy (SABR) for Bone Only Oligometastatic Breast Cancer: A Prospective Clinical Trial

Published: 26 April 2021| Version 1 | DOI: 10.17632/8svmxsp796.1
Contributor:
Steven David

Description

Attached is the study protocol

Files

Categories

Breast Cancer, Stereotactic Radiotherapy, Oligometastatic Therapy

Licence